CRYSTAL LOWDER-TIBBS: Open Payments
NPI 1811509599 · BOONES MILL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 57 payments from 17 companies in 2025. Trend: 2023 $1,514 · 2024 $1,240 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| ABBVIE INC. | 11 | $140 |
| PFIZER INC. | 9 | $135 |
| Lilly USA, LLC | 4 | $120 |
| Corcept Therapeutics | 5 | $112 |
| Novo Nordisk Inc | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $34 |
Products named: VRAYLAR, Korlym, AIRSUPRA, REXULTI, NURTEC ODT, MOUNJARO, HETLIOZ, FARXIGA.
Industry payments across VA — which companies pay providers there.
